Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biohaven Ltd. Common Shares (NY:BHVN)

8.930 -0.030 (-0.33%)
Official Closing Price Updated: 7:00 PM EDT, Mar 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,125,525
Open 8.900
Bid (Size) 8.980 (3,000)
Ask (Size) 9.980 (100)
Prev. Close 8.960
Today's Range 8.855 - 9.270
52wk Range 7.480 - 31.18
Shares Outstanding 100
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
This $8.9 Million Buy Targets a Stock Down 68% With $322 Million in Cash ↗
Biohaven develops clinical-stage therapies for neurological and immunoscience disorders, with no commercialized products to date. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
XENE Stock Rallies 50% On Epilepsy Trial Data, But One Analyst Thinks Rival Biohaven Still Has ‘Room To Differentiate’ ↗
Xenon said that the late-stage study met its primary endpoint of median percent change from baseline in monthly FOS frequency to week 12 in both the 25 mg and 15 mg dose groups compared to placebo. 
Via Stocktwits

Performance

YTD
-17.6%
-17.6%
1 Month
-21.6%
-21.6%
3 Month
-18.8%
-18.8%
6 Month
-39.9%
-39.9%
1 Year
-68.7%
-68.7%

More News

Read More
News headline image
SSR Mining Stock Up 180% as New $5 Million Stake Signals Gold Conviction ↗
Via The Motley Fool
Topics ETFs Regulatory Compliance
Biohaven Ltd. (NYSE:BHVN) Posts Narrower-Than-Expected Q4 2025 Loss Amid Clinical Progress ↗
Via Chartmill
News headline image
Nuvation Bio Stock Up 130% This Past Year as One Fund Discloses $3 Million Buy ↗
Via The Motley Fool
Topics Regulatory Compliance
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
News headline image
Biohaven Ltd. (BHVN): A High-Stakes Clinical Crossroad in Neuroscience and Immunology
Via PredictStreet
Topics Economy Intellectual Property
News headline image
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
News headline image
Biohaven’s Phase II Depression Trial Falls Short, But Analysts Downplay Impact – Wall Street Looks Ahead To Epilepsy Data ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
Thursday's after hours session: top gainers and losers ↗
Via Chartmill
News headline image
Which stocks are moving after the closing bell on Wednesday? ↗
Via Chartmill
News headline image
Biohaven Stock Slumps After Hours As Failed Depression Study Adds To A Brutal 2025 — Retail Eyes Epilepsy And Obesity Catalysts ↗
Via Stocktwits
News headline image
Biohaven Insiders Bet $33 Million on a Turnaround ↗
Via MarketBeat
News headline image
Biohaven's Chief Accounting Officer Scooped Up 17,000 Shares. Is the Stock a Buy? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Is Teladoc Stock a Buy After Oracle Investment Management Upped Its Stake? ↗
Via The Motley Fool
News headline image
FLEX LNG, Biohaven And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
Via Benzinga
News headline image
Why LightPath Technologies Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
These stocks are moving in today's session ↗
Via Chartmill
News headline image
Biohaven Stock Hits 52-Week Low, Cuts R&D Spending After FDA Rejection ↗
Via Benzinga
News headline image
Keep an eye on the top gainers and losers in Wednesday's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
News headline image
Crude Oil Down 1%; Solid Power Shares Spike Higher ↗
Via Benzinga
News headline image
Wednesday's session: gap up and gap down stocks ↗
Via Chartmill
News headline image
Dow Surges 100 Points; McDonald's Posts Downbeat Earnings ↗
Via Benzinga
Topics Stocks
News headline image
Biohaven Craters After FDA Unexpectedly Rejects Its High-Profile Drug ↗
Via Investor's Business Daily
Topics Earnings

Frequently Asked Questions

Is Biohaven Ltd. Common Shares publicly traded?
Yes, Biohaven Ltd. Common Shares is publicly traded.
What exchange does Biohaven Ltd. Common Shares trade on?
Biohaven Ltd. Common Shares trades on the New York Stock Exchange
What is the ticker symbol for Biohaven Ltd. Common Shares?
The ticker symbol for Biohaven Ltd. Common Shares is BHVN on the New York Stock Exchange
What is the current price of Biohaven Ltd. Common Shares?
The current price of Biohaven Ltd. Common Shares is 8.930
When was Biohaven Ltd. Common Shares last traded?
The last trade of Biohaven Ltd. Common Shares was at 03/20/26 07:00 PM ET
What is the market capitalization of Biohaven Ltd. Common Shares?
The market capitalization of Biohaven Ltd. Common Shares is 893.00
How many shares of Biohaven Ltd. Common Shares are outstanding?
Biohaven Ltd. Common Shares has 893 shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.